DNP 960A Topic 7 interim data review example

DPI Project: Part II Grand Canyon University Free custom sample in 24 to 48h

This DNP 960A Topic 7 sample paper reviews statin outreach data at the midpoint of implementation and explains why four points above the median are not yet a signal. It forms part of GCU DNP 960A, DPI Project: Part II, listed as DNP-960A, a core course of Grand Canyon University's DNP. The run chart tracks the 12-month statin proportion, adjusted for the 50 patients transferred out. Three of four post-launch points reflect outreach, and the shift rule of Perla and colleagues needs six. The interim look still establishes that measurement works. Seasonal differences between baseline and implementation are named, three findings that would change the plan are listed and five actions follow.

CourseDNP 960A DPI Project: Part II
TopicTopic 7
Paper typeInterim data review
LengthAbout 1,040 words, 3 pages
FormatAPA 7 student paper
SchoolGrand Canyon University (GCU)
ProgramDNP
UpdatedOctober 2026

Free sample paper for DNP 960A Topic 7

1

Four Points Above the Median Is Not Yet a Signal: An Interim Review of Statin Outreach Data at the Midpoint of Implementation

[Author Name]

College of Nursing and Health Care Professions, Grand Canyon University

DNP-960A: DPI Project: Part II

Topic 7 Assignment

[Instructor Name]

January 7, 2030

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

What this page is doingThe title states what the chart does not yet show, which is the discipline the interim review is meant to practice. The network and all figures are composites.
2

Four Points Above the Median Is Not Yet a Signal: An Interim Review of Statin Outreach Data at the Midpoint of Implementation

The Chart

Table 1

Monthly Primary Measure, Baseline and First Four Months of Implementation

MonthPercent with a statin order or fill in prior 12 monthsPeriod
March 202955.8Baseline
April56.3Baseline
May56.0Baseline
June56.9Baseline
July57.2Baseline
August57.3Baseline
September57.1Implementation begins September 4; value covers data through August 31
October58.9Implementation
November61.5Implementation
December63.7Implementation

The primary measure for the statin outreach project is the proportion of the cohort with a statin order or pharmacy fill in the preceding 12 months, recalculated monthly and adjusted to exclude the 50 patients transferred with Clinic E in November from every month, so the series describes the same population throughout. Table 1 gives the ten monthly values from March 2029 through December 2029. Each value comes from the extract run early in that month and covers data through the end of the month before, so the September value predates any outreach, and only October through December reflect it. The baseline median, from March through August, is 56.6 percent, and it is carried forward on the chart.

What the Chart Does and Does Not Show

Four values have been extracted since launch, and because of the one-month lag, three of them reflect outreach. All four are above the baseline median, and the last three rise steadily, by 1.8, 2.6 and 2.2 points. It is tempting to call that improvement. It does not yet satisfy any rule for special cause. For a shift, the rule wants at least six successive monthly values above the median, or six below it; this chart has four. A trend requires five consecutive points all rising, and the run from September to December is four points long, because September dipped slightly below August. No point is so far outside the baseline range that everyone would agree it is unusual (Perla et al., 2011). The honest statement is that the chart is consistent with an improvement under way and does not yet demonstrate one. Two more months, January and February, would complete a shift if both stay above 56.6 percent, which is the test the final report will apply.

The new-starts measure moves faster, as intended, and is easier to read. New statin starts averaged about 9 a month in the six baseline months, counted retrospectively. Since launch they have been 24 in September, counted from signed orders for the first two weeks, 31 in October, 27 in November and 22 in December. December's lower figure coincides with the holidays, when fewer patients answered calls and several prescribers were away.

What this page is doingThe review states how many points exist since launch and applies the rules to them, declining to call a promising pattern a signal before the chart supports it.
3

What the Interim Look Does Establish

Even without a conclusion about effect, the interim review establishes several things that matter for the rest of the project. The extract has run on schedule every month since September, on the fifth working day, with no gaps. The denominator has held stable once the Clinic E transfer is accounted for, varying by fewer than five patients a month from individual departures. One field is populated in only a minority of eligible records: the second belief questionnaire, completed at the follow-up call, exists for 49 of the 154 patients reached so far, 32 percent, because the follow-up call is itself often missed. The mechanism analysis will almost certainly be descriptive. And two groups are arriving at markedly different rates: patients reachable in the daytime complete follow-up at 76 percent, patients reachable only in the evening at 41 percent, the pattern first seen in the stakeholder analysis.

The Seasons the Two Periods Span

The baseline covers March through August and the implementation period covers September through February. The two periods are not seasonally equivalent. Autumn and winter bring more primary care visits in this network, largely for respiratory illness and vaccinations, and every visit is a chance for a clinician to raise a statin, independent of the project. Last year, without any outreach, the same measure in the full diabetes population rose about one point between September and December, which suggests part of the current rise is seasonal. The final report will state this and compare the rise in this cohort with the rise in patients aged 55 to 75, who are not receiving outreach, as an informal check on how much of the change the season alone explains (Provost & Murray, 2011).

What Would Change the Plan Before February

The interim review is not only a waiting exercise. Three findings, if they appeared in January, would change what the project does in its last two months. If new starts fell below 15 in January, well above the baseline of about 9 but far below the autumn months, it would suggest the outreach list is exhausting the patients most willing to start, and the care managers would shift their remaining hours toward follow-up calls, which protect the starts already made. If muscle symptom contacts among new starters rose above the 15 percent harm threshold, outreach would pause while the prescribing protocol was reviewed; so far, 11 of 104 new starters, about 11 percent, have called or visited with muscle symptoms, and 4 stopped the statin. And if the evening follow-up rate did not improve after the conversation with the evening clinic, the project would stop trying to fix it within the implementation period and report the gap as a finding.

None of these would be decided from the primary measure, which moves too slowly to guide action within two months. They are decided from the faster measures the plan added for exactly this purpose, which is the practical reason for having them.

What Happens Next

The review sets five actions. The January and February points will be added and the shift rule applied at the end of February, not before. The comparison with the 55 to 75 group will be run for the same months. The evening follow-up gap will be addressed through the conversation with the evening clinic's lead nurse, now scheduled, and the result reported whatever it is. The mechanism analysis will be reported descriptively, with the reason stated. And no interim result will be presented to the network as evidence of effect until the chart meets its rules (Ogrinc et al., 2016).

References

Ogrinc, G., Davies, L., Goodman, D., Batalden, P., Davidoff, F., & Stevens, D. (2016). SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): Revised publication guidelines from a detailed consensus process. BMJ Quality & Safety, 25(12), 986-992. https://doi.org/10.1136/bmjqs-2015-004411

Perla, R. J., Provost, L. P., & Murray, S. K. (2011). The run chart: A simple analytical tool for learning from variation in healthcare processes. BMJ Quality & Safety, 20(1), 46-51. https://doi.org/10.1136/bmjqs.2009.037895

Provost, L. P., & Murray, S. K. (2011). The health care data guide: Learning from data for improvement. Jossey-Bass.

The DNP-960A Topic 7 assignment instructions

Topic 7 in DNP-960A asks students to review their data partway through implementation. Strong reviews present the chart with any adjustments, apply the standard rules honestly and resist calling a trend before the rules are met, even when points look encouraging. Students should state what the interim look does establish, such as whether measurement is working and delivery is on track, consider differences between periods that could explain change, such as seasons, and name findings that would change the plan before the end. The review should close with specific next actions, including when the rules will be applied to the full series. The chart itself should be shown with its median line and annotations, and each rule should be quoted from its published source.

Inside the DNP 960A Topic 7 example

The finished example resists its own numbers. A chart carries the median from the baseline period and every point recorded since, with the launch annotated on the line. The count of points since launch is stated, along with the plain observation that the pattern does not yet satisfy any rule for special cause. What the interim look does establish is then reported in its own section: the extract runs on schedule, the denominator has held stable, one field is populated in a minority of eligible records, and two groups are arriving at markedly different rates. A short passage compares the seasons the two periods span. The closing list sets out what must hold at the end for a final comparison to be defensible.

DNP 960A Topic 7 rubric: what Excellent looks like

Faculty reward restraint at the midpoint. An Excellent review shows four points above the baseline median and explains why Perla and colleagues' shift rule needs six before a signal is claimed. Credit goes to adjusting the measure for 50 transferred patients and noting the one-month lag. The rubric values stating what the interim look establishes, such as an extract running on schedule, with Provost and Murray. Strong reviews name seasonal differences between periods. Top marks go to three findings that would change the plan and five dated actions.

Common DNP 960A Topic 7 mistakes, and how to avoid them

Declaring improvement from a handful of points is the failure this assignment exists to catch, and at doctoral level it reads as impatience rather than as optimism. A second weakness is a chart with no baseline period, which leaves the reader nothing to judge the recent points against. Marks also go for percentages computed on very small denominators, since a two-case movement can swing a rate enough to look like a trend. Seasonal differences between the periods, left unmentioned, undermine the comparison later. Reviews reporting no quality findings have wasted the one thing an interim look reliably delivers. Charts with the launch unannotated hide the only event that matters on them.

Get a DNP-960A Topic 7 example written to your instructions

Send the DNP-960A Topic 7 assignment instructions and the rubric your classroom posts, with any charting convention your section requires. We write a custom example to those criteria, with the baseline median carried, special cause rules named and unmet, quality findings reported and end conditions listed, in 24 to 48 hours. The first one is free.

More DNP 960A papers and DNP samples

DNP 960A Topic 7 questions, answered

Can I say the project appears to be working?

Not from an interim look, and the restraint is marked rather than penalized. A handful of points after a launch will often drift in the hoped-for direction for reasons that include attention, seasonality and ordinary variation. State what is observed, state that no rule for special cause has been met, and say what would have to accumulate before the observation could support anything.

What is an interim look actually for?

Establishing that the machinery works. It confirms the extract runs, the denominator is stable, the fields are populated, and the groups are arriving as expected. Those are real findings and every one of them can still be fixed at this stage. An effect estimate cannot be fixed later, which is exactly why the interim report should not be spending its length on one.

Do you analyze my data or produce my results?

No. Your figures come from your site under permissions issued to you, and the analysis is part of the doctoral work that has to be yours. What a sample can show is the shape of an interim report: how a chart is annotated, how restraint is stated so a reader is not left guessing, and how quality findings are separated from an effect claim.

Where can I find a free DNP 960A Topic 7 sample paper?

The interim review for DNP 960A Topic 7 covers the chart, what it does and does not show, what the interim look establishes, the seasons the two periods span, what would change the plan and what happens next. Paste in your DNP 960A Topic 7 prompt and a free review follows.

Can I say the project appears to be working in DNP 960A Topic 7?

Not from an interim look. Four points above the median fall short of the six-point shift rule, so the review reports them as encouraging and waits for February.